Market Research

Molecular Oncology Market (Product: Instruments, Reagents, and Others; and Cancer Type:  Lung Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2

Best Price Guarantee Length Publisher Published Date SKU
from $5,795 145 Pages Transparency Market Research Pvt. Ltd. May, 2024 TNPR18955034
Best Price Guarantee
Price from $5,795
Length 145 Pages
Publisher Transparency Market Research Pvt. Ltd.
Published Date May, 2024
SKU TNPR18955034

Molecular Oncology Market (Product: Instruments, Reagents, and Others; and Cancer Type:  Lung Cancer, Breast Cancer, Colorectal Cancer, Ovarian Cancer, Pancreatic Cancer, and Others) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2024-2034


Molecular Oncology Market – Scope of Report

TMR’s report on the global molecular oncology market studies the past as well as the current growth trends and opportunities to gain valuable insights of the indicators of the market during the forecast period from 2024 to 2034. The report provides revenue of the global molecular oncology market for the period 2018–2034, considering 2024 as the base year and 2034 as the forecast year. The report also provides the compound annual growth rate (CAGR %) of the global molecular oncology market from 2024 to 2034.

The report has been prepared after an extensive research. Primary research involved bulk of the research efforts, wherein analysts carried out interviews with key opinion leaders, industry leaders, and opinion makers. Secondary research involved referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the molecular oncology market.

Secondary research also included Internet sources, statistical data from government agencies, websites, and trade associations. Analysts employed a combination of top-down and bottom-up approaches to study various attributes of the global molecular oncology market.

The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments included in the scope of the study. Moreover, the report throws light on the changing competitive dynamics in the global molecular oncology market. These serve as valuable tools for existing market players as well as for entities interested in participating in the global molecular oncology market.

The report delves into the competitive landscape of the global molecular oncology market. Key players operating in the global molecular oncology market have been identified and each one of these has been profiled in terms of various attributes. Company overview, financial standings, recent developments, and SWOT are the attributes of players in the global molecular oncology market profiled in this report.

Key Questions Answered in Global molecular oncology Market Report
  • What is the sales/revenue generated by molecular oncology across all regions during the forecast period?
  • What are the opportunities in the global molecular oncology market?
  • What are the major drivers, restraints, opportunities, and threats in the market?
  • Which regional market is set to expand at the fastest CAGR during the forecast period?
  • Which segment is expected to generate the highest revenue globally in 2034?
  • Which segment is projected to expand at the highest CAGR during the forecast period?
  • What are the market positions of different companies operating in the global market?
Molecular Oncology Market – Research Objectives and Research Approach

The comprehensive report on the global molecular oncology market begins with an overview, followed by the scope and objectives of the study. The report provides detailed explanation of the objectives behind this study and key vendors and distributors operating in the market and regulatory scenario for approval of products.

For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section divided into smaller ones. The report comprises an exhaustive collection of graphs and tables that are appropriately interspersed. Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.

The report analyzes the global molecular oncology market in terms of product, end-user, and region. Key segments under each criterion have been studied at length, and the market share for each of these at the end of 2034 has been provided. Such valuable insights enable market stakeholders in making informed business decisions for investment in the global molecular oncology market.


1. Preface
  1.1. Market Definition and Scope
  1.2. Market Segmentation
  1.3. Key Research Objectives
  1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Molecular Oncology Market
4. Market Overview
  4.1. Introduction
4.1.1. Product Definition
4.1.2. Industry Evolution / Developments
  4.2. Overview
  4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
  4.4. Global Molecular Oncology Market Analysis and Forecasts, 2020-2034
5. Key Insights
  5.1. Key Mergers & Acquisitions
  5.2. Regulatory Scenario by Region/Globally
  5.3. Prevalence of Cancer
  5.4. COVID-19 Impact Analysis
6. Global Molecular Oncology Market Analysis and Forecasts, By Product
  6.1. Introduction & Definition
  6.2. Key Findings / Developments
  6.3. Market Value Forecast By Product, 2020-2034
6.3.1. Instruments
6.3.2. Reagents
6.3.3. Others
  6.4. Market Attractiveness By Product
7. Global Molecular Oncology Market Analysis and Forecasts, By Application
  7.1. Introduction & Definition
  7.2. Key Findings / Developments
  7.3. Market Value Forecast By Application, 2020-2034
7.3.1. Lung Cancer
7.3.2. Breast Cancer
7.3.3. Colorectal Cancer
7.3.4. Ovarian Cancer
7.3.5. Pancreatic Cancer
7.3.6. Others
  7.4. Market Attractiveness By Application
8. Global Molecular Oncology Market Analysis and Forecasts, By Technology
  8.1. Introduction & Definition
  8.2. Key Findings / Developments
  8.3. Market Value Forecast By Technology, 2020-2034
8.3.1. PCR (rt-PCR, d-PCR)
8.3.2. NGS (Next Generation Sequencing)
8.3.3. Microarray
8.3.4. FISH (Fluorescent in situ-hybridization)
8.3.5. Others
  8.4. Market Attractiveness By Technology
9. Global Molecular Oncology Market Analysis and Forecasts, By End-user
  9.1. Introduction & Definition
  9.2. Key Findings / Developments
  9.3. Market Value Forecast By End-user, 2020-2034
9.3.1. Hospitals and Clinics
9.3.2. Diagnostic Laboratories
9.3.3. Cancer Centers and Specialty Clinics
9.3.4. Others (Government and Public Health Agencies)
  9.4. Market Attractiveness By End-user
10. Global Molecular Oncology Market Analysis and Forecasts, By Region
  10.1. Key Findings
  10.2. Market Value Forecast By Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
  10.3. Market Attractiveness By Country/Region
11. North America Molecular Oncology Market Analysis and Forecast
  11.1. Introduction
11.1.1. Key Findings
  11.2. Market Value Forecast By Product, 2020-2034
11.2.1. Instruments
11.2.2. Reagents
11.2.3. Others
  11.3. Market Value Forecast By Application, 2020-2034
11.3.1. Lung Cancer
11.3.2. Breast Cancer
11.3.3. Colorectal Cancer
11.3.4. Ovarian Cancer
11.3.5. Pancreatic Cancer
11.3.6. Others
  11.4. Market Value Forecast By Technology, 2020-2034
11.4.1. PCR (rt-PCR, d-PCR)
11.4.2. NGS (Next Generation Sequencing)
11.4.3. Microarray
11.4.4. FISH (Fluorescent in situ-hybridization)
11.4.5. Others
  11.5. Market Value Forecast By End-user, 2020-2034
11.5.1. Hospitals and Clinics
11.5.2. Diagnostic Laboratories
11.5.3. Cancer Centers and Specialty Clinics
11.5.4. Others (Government and Public Health Agencies)
  11.6. Market Value Forecast By Country, 2020-2034
11.6.1. U.S.
11.6.2. Canada
  11.7. Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Application
11.7.3. By Technology
11.7.4. By End-user
11.7.5. By Country
12. Europe Molecular Oncology Market Analysis and Forecast
  12.1. Introduction
12.1.1. Key Findings
  12.2. Market Value Forecast By Product, 2020-2034
12.2.1. Instruments
12.2.2. Reagents
12.2.3. Others
  12.3. Market Value Forecast By Application, 2020-2034
12.3.1. Lung Cancer
12.3.2. Breast Cancer
12.3.3. Colorectal Cancer
12.3.4. Ovarian Cancer
12.3.5. Pancreatic Cancer
12.3.6. Others
  12.4. Market Value Forecast By Technology, 2020-2034
12.4.1. PCR (rt-PCR, d-PCR)
12.4.2. NGS (Next Generation Sequencing)
12.4.3. Microarray
12.4.4. FISH (Fluorescent in situ-hybridization)
12.4.5. Others
  12.5. Market Value Forecast By End-user, 2020-2034
12.5.1. Hospitals and Clinics
12.5.2. Diagnostic Laboratories
12.5.3. Cancer Centers and Specialty Clinics
12.5.4. Others (Government and Public Health Agencies)
  12.6. Market Value Forecast By Country, 2020-2034
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
  12.7. Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Application
12.7.3. By Technology
12.7.4. By End-user
12.7.5. By Country
13. Asia Pacific Molecular Oncology Market Analysis and Forecast
  13.1. Introduction
13.1.1. Key Findings
  13.2. Market Value Forecast By Product, 2020-2034
13.2.1. Instruments
13.2.2. Reagents
13.2.3. Others
  13.3. Market Value Forecast By Application, 2020-2034
13.3.1. Lung Cancer
13.3.2. Breast Cancer
13.3.3. Colorectal Cancer
13.3.4. Ovarian Cancer
13.3.5. Pancreatic Cancer
13.3.6. Others
  13.4. Market Value Forecast By Technology, 2020-2034
13.4.1. PCR (rt-PCR, d-PCR)
13.4.2. NGS (Next Generation Sequencing)
13.4.3. Microarray
13.4.4. FISH (Fluorescent in situ-hybridization)
13.4.5. Others
  13.5. Market Value Forecast By End-user, 2020-2034
13.5.1. Hospitals and Clinics
13.5.2. Diagnostic Laboratories
13.5.3. Cancer Centers and Specialty Clinics
13.5.4. Others (Government and Public Health Agencies)
  13.6. Market Value Forecast By Country, 2020-2034
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
  13.7. Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Application
13.7.3. By Technology
13.7.4. By End-user
13.7.5. By Country
14. Latin America Molecular Oncology Market Analysis and Forecast
  14.1. Introduction
14.1.1. Key Findings
  14.2. Market Value Forecast By Product, 2020-2034
14.2.1. Instruments
14.2.2. Reagents
14.2.3. Others
  14.3. Market Value Forecast By Application, 2020-2034
14.3.1. Lung Cancer
14.3.2. Breast Cancer
14.3.3. Colorectal Cancer
14.3.4. Ovarian Cancer
14.3.5. Pancreatic Cancer
14.3.6. Others
  14.4. Market Value Forecast By Technology, 2020-2034
14.4.1. PCR (rt-PCR, d-PCR)
14.4.2. NGS (Next Generation Sequencing)
14.4.3. Microarray
14.4.4. FISH (Fluorescent in situ-hybridization)
14.4.5. Others
  14.5. Market Value Forecast By End-user, 2020-2034
14.5.1. Hospitals and Clinics
14.5.2. Diagnostic Laboratories
14.5.3. Cancer Centers and Specialty Clinics
14.5.4. Others (Government and Public Health Agencies)
  14.6. Market Value Forecast By Country, 2020-2034
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
  14.7. Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Application
14.7.3. By Technology
14.7.4. By End-user
14.7.5. By Country
15. Middle East & Africa Molecular Oncology Market Analysis and Forecast
  15.1. Introduction
15.1.1. Key Findings
  15.2. Market Value Forecast By Product, 2020-2034
15.2.1. Instruments
15.2.2. Reagents
15.2.3. Others
  15.3. Market Value Forecast By Application, 2020-2034
15.3.1. Lung Cancer
15.3.2. Breast Cancer
15.3.3. Colorectal Cancer
15.3.4. Ovarian Cancer
15.3.5. Pancreatic Cancer
15.3.6. Others
  15.4. Market Value Forecast By Technology, 2020-2034
15.4.1. PCR (rt-PCR, d-PCR)
15.4.2. NGS (Next Generation Sequencing)
15.4.3. Microarray
15.4.4. FISH (Fluorescent in situ-hybridization)
15.4.5. Others
  15.5. Market Value Forecast By End-user, 2020-2034
15.5.1. Hospitals and Clinics
15.5.2. Diagnostic Laboratories
15.5.3. Cancer Centers and Specialty Clinics
15.5.4. Others (Government and Public Health Agencies)
  15.6. Market Value Forecast By Country, 2020-2034
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
  15.7. Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Application
15.7.3. By Technology
15.7.4. By End-user
15.7.5. By Country
16. Competition Landscape
  16.1. Market Player - Competition Matrix (By Tier and Size of companies)
  16.2. Company Profiles
16.2.1. Thermo Fisher Scientific Inc.
16.2.1.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.1.2. Product Portfolio
16.2.1.3. Financial Overview
16.2.1.4. SWOT Analysis
16.2.1.5. Strategic Overview
16.2.2. Illumina, Inc.
16.2.2.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.2.2. Product Portfolio
16.2.2.3. Financial Overview
16.2.2.4. SWOT Analysis
16.2.2.5. Strategic Overview
16.2.3. Qiagen N.V.
16.2.3.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.3.2. Product Portfolio
16.2.3.3. Financial Overview
16.2.3.4. SWOT Analysis
16.2.3.5. Strategic Overview
16.2.4. Agilent Technologies, Inc.
16.2.4.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.4.2. Product Portfolio
16.2.4.3. Financial Overview
16.2.4.4. SWOT Analysis
16.2.4.5. Strategic Overview
16.2.5. Abbott Laboratories
16.2.5.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.5.2. Product Portfolio
16.2.5.3. Financial Overview
16.2.5.4. SWOT Analysis
16.2.5.5. Strategic Overview
16.2.6. Bio-Rad Laboratories, Inc.
16.2.6.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.6.2. Product Portfolio
16.2.6.3. Financial Overview
16.2.6.4. SWOT Analysis
16.2.6.5. Strategic Overview
16.2.7. Roche Diagnostics
16.2.7.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.7.2. Product Portfolio
16.2.7.3. Financial Overview
16.2.7.4. SWOT Analysis
16.2.7.5. Strategic Overview
16.2.8. Genomic Health, Inc.
16.2.8.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.8.2. Product Portfolio
16.2.8.3. Financial Overview
16.2.8.4. SWOT Analysis
16.2.8.5. Strategic Overview
16.2.9. Myriad Genetics, Inc.
16.2.9.1. Company Overview (HQ, Business Segments, Employee Strength)
16.2.9.2. Product Portfolio
16.2.9.3. Financial Overview
16.2.9.4. SWOT Analysis
16.2.9.5. Strategic Overview

$5,795
$8,795
$11,795

Research Assistance

US: 800.298.5699
Int'l: +1.240.747.3093
Live help
Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook

Other tasks

Cookie Settings